Contraception Journal

🚨 Post-Dobbs, self-managed medication abortion awareness in Ohio remains low. Many women confuse Plan B with abortion pills, and awareness is lowest among Black, Asian, and less-educated women. These disparities raise urgent equity concerns. #MedSky

🔗: www.contraceptionjournal.org/article/S001...

Applications are open for the position of Editor-in-Chief at Contraception Journal. Send over your CV and a letter of interest (deadline: August 4th 2025). Find the full informations and requirements at contraceptionjournal.org

We’re hiring an Editor-in-Chief! 📢

Contraception (us!), the official journal of the Society of Family Planning, is inviting applications for EIC starting January 2026.

📆 Apply by Aug 4, 2025
📩 CV + letter to a.boccelli@elsevier.com

⬇️ Full details

🔗: contraceptionjournal.org/call-for-editor

A quote emphasizing that taking responsibility for preventing pregnancy is not gender-specific. It states that enabling men to have contraceptive options is long overdue and would be revolutionary. While only women can physically bear children, the responsibility for preventing pregnancy should be shared. The quote is attributed to a 50-year-old, married individual with one child. The post references a research article titled "Motivations to use a novel hormonal male contraceptive: Perspectives from male contraceptive clinical trial participants" by Jessica D. Gipson, Marta Bornstein, Andrew Duong, and Brian T. Nguyen, published on contraceptionjournal.org.

Abstract of a research article titled "Motivations to use a novel hormonal male contraceptive." The study explores the perspectives of male clinical trial participants on using a new hormonal contraceptive method. Key themes include motivations such as shared responsibility, partner support, and reproductive control. The research highlights interest in male contraceptive options and broader implications for gender equity in family planning.

💊What motivates men to try hormonal birth control?

This new study shares insights from clinical trial participants—revealing personal, relational, and societal reasons driving interest in male contraceptives and its importance for the future #MedSky

🔗: www.contraceptionjournal.org/article/S001...

🚹 What’s next in male birth control?

Contraception’s new Special Issue explores the future of male contraception—from hormonal gels to non-hormonal innovations—and why expanding options matters more than ever. Take a look at our 10 articles👇 #MedSky

🔗: www.sciencedirect.com/special-issu...

Who’s getting left behind in birth control access at school?

This research shows major racial and sex disparities in teen contraceptive use—especially among Black, Hispanic, and Asian girls. Reliable methods remain out of reach for many. #MedSky

🔗: www.contraceptionjournal.org/article/S001...

👉Our new study shows denying abortion access to people with chronic kidney disease leads to worse health outcomes, higher costs, and more deaths. Providing access is a cost-effective, life-saving strategy.

💡Abortion access is essential medical care.

🔗 www.contraceptionjournal.org/article/S001...

Effects of estetrol/drospirenone on Self-Reported Physical and Emotional Premenstrual and Menstrual Symptoms: Data from the Phase 3 Clinical Trial in the United States and Canada To describe the effects of estetrol 15mg/drospirenone 3mg on physical and emotional premenstrual and menstrual symptoms in a North American population.

Can birth control do more than prevent pregnancy?

First-time users of estetrol/drospirenone reported less period pain, fatigue, and mood swings. Switchers from other pills saw stable symptoms, suggesting added benefits for new users. #MedSky

🔗: www.contraceptionjournal.org/article/S001...

Preclinical development of a novel injectable hydrogel for vas-occlusion The objective of this work is to outline the preclinical development of ADAM, an injectable, two-component polyethylene glycol hydrogel designed for long-lasting and nonpermanent vas-occlusive contrac...

Could male birth control be as simple as an injection?💉

ADAM, a new injectable hydrogel, blocks sperm, sets in 30 secs, and is safe, reversible, and effective in preclinical tests. A promising step toward nonpermanent male contraception. #MedSky

🔗: www.contraceptionjournal.org/article/S001...

Where do people who use birth control get it, and does insurance matter? This study found most use private providers but those with public or no insurance often rely on community health centers and family planning clinics highlighting need for access.

🔗: www.contraceptionjournal.org/article/S001...

Pennsylvania Medicaid policy and rural hospital implementation of immediate postpartum contraception To assess the importance of Pennsylvania Medicaid immediate postpartum long-acting reversible contraception (IPLARC) reimbursement policy changes for hospital implementation of IPLARC by rurality.

Does policy change equal better access?💡

Six years after Pennsylvania Medicaid expanded IPLARC reimbursement, fewer than half of hospitals offer postpartum IUDs or implants—especially in rural areas. More support is needed for equitable access.

🔗: www.contraceptionjournal.org/article/S001...

‘‘Inserting the etonorgestrel implant into the thigh: A case report’’ Etonorgestrel implant is inserted on the inner surface of the non-dominant medial upper arm in women, over the triceps area. However, this case report aims to describe an alternative insertion site fo...

Can the thigh be a safe site for etonorgestrel implant insertion?

This case report highlights a successful thigh insertion in a patient with arteriovenous fistulas, emphasizing the need for alternative options.

🔗: www.contraceptionjournal.org/article/S001...

Can Implanon NXT cause symptomatic hypotension?

This case report describes recurrent hypotensive episodes after insertion, resolving upon removal, highlighting the need for awareness, early recognition, and intervention.

🔗: www.contraceptionjournal.org/article/S001...

Can Dilation and Evacuation be safely performed after trachelectomy and abdominal cerclage?

This case report shows a successful D&E at 15 weeks with mifepristone preparation, suggesting D&E may be a viable option for second-trimester termination.

🔗: www.contraceptionjournal.org/article/S001...

Can the JADA system do more than we thought?

Proven for hemorrhage control at 34+ weeks, this case report highlights its successful use after an induced abortion at 12 weeks, suggesting a new role in managing uterine atony in earlier gestations.

🔗: www.contraceptionjournal.org/article/S001...

Why do case reports matter? 👩‍⚕️📖

Case reports are like medical detective stories, documenting real patient experiences, rare cases, and new treatments. Unlike large studies, they offer quick, valuable insights that drive innovation.

Here are four cases that challenge reproductive healthcare norms!

Research on estetrol/drospirenone highlights cardiovascular safety. Among 1,400+ participants with risk factors only 0.2% stopped due to hypertension all with high-normal BP and other risks. Findings suggest good tolerance but more research is needed.

🔗: www.contraceptionjournal.org/article/S001...

Thanks for your support for male contraceptive development! We've shared your question with Brian Nguyen, an author, and he provided an in depth response we've sent you via chat (due to the strict character limit imposed, we couldn't text it here directly). Hope you'll find it useful!

Does contraception use align with people's needs? This study validates the PFM Index, a person-centered measure that values both use and nonuse based on preferences. Findings highlight the role of education, partner support, and systemic barriers.

🔗: www.contraceptionjournal.org/article/S001...

TikTok’s take on the DMPA shot is largely negative, driven by personal stories over medical input. With side effects in focus and factual content limited, many may dismiss this contraceptive option before consulting a healthcare provider.

🔗: www.contraceptionjournal.org/article/S001...

TikTok’s birth control talk centers on hormonal side effect concerns, with #HormonalBirthControl mostly negative. Meanwhile, #FertilityAwarenessMethod gets more shares, led by non-experts. Medical professionals can help provide balanced info.

🔗Read more: www.contraceptionjournal.org/article/S001...

TikTok drives abortion talk post-Roe, but top videos focus on politics and personal stories, not health info. With little input from medical providers, there’s a gap in practical guidance—one clinicians and advocates can help fill.

🔗Read more : www.contraceptionjournal.org/article/S001...

Popular contraception videos on TikTok: An assessment of content topics This study aimed to explore the contraception content topics on the highly popular social media platform TikTok to understand this influential information source patients may bring into birth control ...

TikTok is shaping how people learn about contraception, but most content comes from non-experts. With billions of views, this information influences patient decisions, making it crucial for clinicians to understand and address its impact.

🔗Read more : www.contraceptionjournal.org/article/S001...

TikTok is shaping conversations on contraception and abortion, but it’s not all accurate info. These four studies explore how personal stories and political views dominate, with a big opportunity for healthcare professionals to step in and provide balanced, reliable education. Take a look! 📲 #MedSky

Association of willingness to use hormonal contraception with knowledge: A national survey To determine if willingness to use and concern with using hormonal contraception (HC) is associated with knowledge about HC.

Women with more knowledge about hormonal contraception are more likely to use it—but 80% still have concerns. This study highlights the need for better education to support informed choices and dispel common myths. Take a look!

🔗: www.contraceptionjournal.org/article/S001...

Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review Genetic studies in mice have demonstrated that retinoic acid receptor alpha (RARα) deficiency leads to male infertility without affecting overall viability, suggesting that pharmacological inhibition ...

🧪 Researchers are developing YCT-529, a selective retinoic acid receptor alpha antagonist, as a potential male contraceptive. Explore its development, preclinical success in reversibly inhibiting sperm production, and progress toward clinical trials.

🔗: www.contraceptionjournal.org/article/S001...

⚖️ Expanding male contraception is key to global reproductive health and gender equity. This review we previously shared highlights how novel methods could ease the burden on women, strengthen health systems, and advance universal access to SRH.

🔗: www.contraceptionjournal.org/article/S001...

Development of a transdermal gel for reversible male contraception While there are several easy-to-use reversible female contraceptives, little is available for men. Introduction of novel, cost-effective male contraceptives could have important downstream global heal...

🧴A transdermal gel for reversible male contraception is in development! This method delivers hormones through the skin, suppressing sperm production while maintaining testosterone levels, offering a promising alternative to existing options.

🔗: www.contraceptionjournal.org/article/S001...

Web traffic and Google Trends data show increased interest in novel male contraception following the Supreme Court’s Dobbs v. Jackson ruling Explore online public interest in male contraception in the United States after the Supreme Court’s Dobbs v. Jackson ruling.

📈 After Dobbs v. Jackson, online interest in male contraception surged. This study using Google Trends and web traffic data shows searches for "male birth control" more than doubled, highlighting shifting conversations on reproductive responsibility.

🔗: www.contraceptionjournal.org/article/S001...

Expanding the focus on male contraception is key to advancing reproductive health. These four new 2025 studies cover everything from shifts in public interest to the development of new contraceptive options, reflecting the evolving landscape of male reproductive health. Take a look 💡 #MedSky

Changes in Contraceptive Method Use, Access, and Experiences of Care During a Statewide Contraceptive Initiative To examine changes in contraceptive use, access, and care experiences during a statewide contraceptive access initiative, Delaware Contraceptive Access Now.

How do statewide initiatives impact contraceptive access?

This study on Delaware’s initiative shows increased awareness of free LARC but mixed changes in use and satisfaction. Insights like these help shape the future of reproductive health policy.

🔗: www.contraceptionjournal.org/article/S001...